The landscape of continuous glucose monitoring (CGM) has reached a critical evolutionary inflection point. For more than two decades, the sector was defined by an intensive engineering competition focused on physical biosensor attributes: minimising sensor lag, improving mean absolute relative difference accuracy, reducing wearability profiles and ensuring seamless integration with insulin pumps and closed-loop systems. However, as physical sensors have achieved near-perfect